Acromegaly Market, Size, Share, Trends, Epidemiology Forecast till 2030

Acromegaly Market, Size, Share, Trends, Epidemiology Forecast till 2030

“DelveInsight Business Research LLP”
DelveInsight’s “Acromegaly Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acromegaly, historical and forecasted epidemiology as well as the Acromegaly market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Acromegaly is a rare and chronic disorder characterized by excess growth hormone secretion and elevated insulin-like growth factor-1 levels, most often caused by a pituitary Adenoma.

 

Epidemiology Insights

  • The total Acromegaly prevalent cases in 2017 was 64,508
  • The diagnosed Acromegaly patient pool cases in 2017 was 49,814 
  • The prevalent population of Acromegaly in the United States in 2017 was 28,671 
  • The prevalent cases of Acromegaly in Japan in 2017 was 10,690
  • EU5 countries occupied around 38.98% of the patient pool amongst 7MM in 2017

 

Acromegaly Market Insight

 

Acromegaly Market Drivers

  • Robust pipeline
  • Increase in Prevalence
  • More efficacious mono and combination therapies

 

Acromegaly Market Barriers

  • Economic burden
  • Low disease awareness and delay in diagnosis
  • No standard cure available

 

Request for sample pages

Table of contents

1. Key Insights

2. Executive Summary of Acromegaly

3. Competitive Intelligence Analysis for Acromegaly

4. Acromegaly: Market Overview at a Glance

4.1. Acromegaly Total Market Share (%) Distribution in 2017

4.2. Acromegaly Total Market Share (%) Distribution in 2030

5. Acromegaly: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Acromegaly Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Acromegaly Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Acromegaly Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Acromegaly Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Acromegaly Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Acromegaly Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Acromegaly Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Acromegaly Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Acromegaly Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Acromegaly Treatment and Management

8.2. Acromegaly Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Acromegaly Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Acromegaly: Seven Major Market Analysis

13.1. Key Findings

13.2. Acromegaly Market Size in 7MM

13.3. Acromegaly Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Acromegaly Total Market Size in the United States

15.1.2. Acromegaly Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Acromegaly Total Market Size in Germany

15.3.2. Acromegaly Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Acromegaly Total Market Size in France

15.4.2. Acromegaly Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Acromegaly Total Market Size in Italy

15.5.2. Acromegaly Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Acromegaly Total Market Size in Spain

15.6.2. Acromegaly Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Acromegaly Total Market Size in the United Kingdom

15.7.2. Acromegaly Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Acromegaly Total Market Size in Japan

15.8.3. Acromegaly Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Acromegaly

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/